Oseltamivir and inhaled zanamivir as influenza prophylaxis in thai health workers: A randomized, double-blind, placebo-controlled safety trial over 16 weeks. [J Antimicrob Chemother 68, (2013) 697-707]

Anekthananon, T; Pukrittayakamee, S; Ratanasuwan, W; Jittamala, P; Werarak, P; Charunwatthana, P; Suwanagool, S; Lawpoolsri, S; Stepniewska, K; Sapchookul, P; Puthavathana, P; Fukuda, C; Lindegardh, N; Tarning, J; White, N; Day, N; Taylor, W

Journal article

Oseltamivir and inhaled zanamivir as influenza prophylaxis in thai health workers: A randomized, double-blind, placebo-controlled safety trial over 16 weeks. [J Antimicrob Chemother 68, (2013) 697-707]

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Anekthananon, T., Pukrittayakamee, S., Ratanasuwan, W., Jittamala, P., Werarak, P., Charunwatthana, P., Suwanagool, S., Lawpoolsri, S., Stepniewska, K., Sapchookul, P., Puthavathana, P., Fukuda, C., Lindegardh, N., Tarning, J., White, N., Day, N., & Taylor, W. (2013). Oseltamivir and inhaled zanamivir as influenza prophylaxis in thai health workers: A randomized, double-blind, placebo-controlled safety trial over 16 weeks. [J Antimicrob Chemother 68, (2013) 697-707]. Journal of Antimicrobial Chemotherapy, 68(7), 1695–1695.

MLA Style

Anekthananon, T, et al. “Oseltamivir and Inhaled Zanamivir as Influenza Prophylaxis in Thai Health Workers: A Randomized, Double-Blind, Placebo-Controlled Safety Trial over 16 Weeks. [J Antimicrob Chemother 68, (2013) 697-707].” Journal of Antimicrobial Chemotherapy, vol. 68, no. 7, 2013, pp. 1695–95.

Chicago Style

Anekthananon, T, S Pukrittayakamee, W Ratanasuwan, et al. 2013. “Oseltamivir and Inhaled Zanamivir as Influenza Prophylaxis in Thai Health Workers: A Randomized, Double-Blind, Placebo-Controlled Safety Trial over 16 Weeks. [J Antimicrob Chemother 68, (2013) 697-707].” Journal of Antimicrobial Chemotherapy 68 (7): 1695–95.
Print